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Introduction 
Cellulitis is an inflammatory skin condition caused by acute infection of the dermal and 
subcutaneous layers of the skin, it refers to a superficial diffuse, spreading skin infection without 
underlying collection of pus.  Cellulitis is a common diagnosis in both inpatients, outpatients as well 
as primary care settings, (Bailey and Kroshinsky, 2011).  It accounts for 3% of attendance to Accident 
and Emergency departments within the United Kingdom (UK), (Haydock et al., 2007). The prevalence 
of cellulitis is increasing year on year, the aging population and increasing levels of obesity are 
thought to contribute to this rise, (Hirschmann and Raugi, 2012a).  Many practitioners will encounter 
patients with suspected cellulitis, however, it’s diagnosis is not always easy.  The identification of 
cellulitis is based solely on clinical findings, and unfortunately there are several other common 
conditions that mimic the clinical signs of cellulitis, creating a potential for misdiagnosis and 
incorrect management, (Hirschmann and Raugi, 2012b).  Hence it is essential that all practitioners 
are skilled in recognising cellulitis, confirming diagnosis and possess the ability and skills to set 
appropriate treatment plans.  Therefore, ensuring all patients receive timely effective care to 
improve their health outcomes. 
Cellulitis 
Cellulitis is an inflammatory skin condition with an infectious origin, classically presenting itself 
through erythema, swelling, warmth, oedema and tenderness over the affected area.  There is often 
poorly defined border separating the affected from the non-affected skin, (Ch'ng and Johar, 2016).   
It is commonly caused by Streptococcus Pyogenes or Staphylococcus Aureus, which resides in the 
interdigital spaces, and cellulitis most often affects the lower limbs, (Corwin et al., 2005).  
Hirschmann and Raugi (2012b) established that 30% - 80% of patients with cellulitis had an 
interdigital skin condition such as eczema, fissures or athletes foot.   Any disruptions in the 
protective barrier of the skin surface will allow bacteria to invade the body and therefore patients 
will be at increased risk of developing cellulitis. 
Incidence 
The incidence and treatment of cellulitis places a significant burden on the National Health Service, 
both in terms of costs and resources.  Lower limb cellulitis accounted for 69,576 hospital admissions 
in England during 2004-2005, with a mean hospital in patient length of stay of 10 days, (Department 
of Health, 2006a) (Halpern et al., 2008).  This accounts for over 400,000 bed days a year, and 
annually the NHS spends £172-£254 million on the admission and treatment of patients with 
cellulitis, (Curtis, 2011, Department of Health, 2006b).   
Risk Factors 
Risk factors for developing cellulitis include older age, obesity, venous insufficiency, saphenous 
venectomy (vein harvest for bypass surgery), trauma, eczema, dermatitis, athletes foot and oedema, 
(Hirschmann and Raugi, 2012a).   Patients with lymphoedema are especially at risk of developing 
cellulitis, due to the disturbances in lymph drainage and associated localised impaired host response 
to infection, (Soo et al., 2008). It is reported that within a one year period 28% of patients with 
lymphoedema will develop cellulitis, and one quarter of this group will required admission to 
hospital for treatment with intravenous antibiotics, (Soo et al., 2008).  Typically the onset of cellulitis 
is between 40 and 60 years, (Ellis Simonsen et al., 2006), cellulitis occurs in equal frequency in men 
and women.  The overall highest predisposing factor of developing cellulites is a previous episode of 
cellulitis, reported annual recurrence rates are between 8 – 20%, (Hirschmann and Raugi, 2012b).  
Diagnosis 
Cellulitis is one of the most common mis-diagnosed conditions, with as many as one third of patients 
are being diagnosed incorrectly, (Hirschmann and Raugi, 2012b).  In the region of 132,000 bed days 
and £84.5 million pounds per year is wasted as a result of inaccurate diagnosis, (Levell et al., 2011).  
Levell et al. (2011) study also showed that a third of patients (33%) referred with lower limb cellulitis 
had an alternative diagnosis, and of the confirmed cases of cellulitis 28% had another skin condition 
which if treated simultaneously would speed recovery and reduce the risk of recurrence.  This mis-
diagnosis clearly has other impacts in terms of patient expectations, treatment delays and wider 
public health risks due to the potential inappropriate use of antibiotics.   Other conditions that can 
mimic the clinical features of cellulitis include: varicose eczema, venous hypertension, and 
lipodermatosclerosis, vasculitis, necrotizing fasciitis, deep vein thrombosis, septic arthritis, acute 
gout and thrombophlebitis, (NICE, 2015). 
Clinical signs of cellulitis include pyrexia, general malaise, pain, and  patients often feel generally 
unwell reporting chills or sweating, (Gunderson, 2011, Wingfield, 2012).   These systemic symptoms 
may accompany or precede the acute onset of skin changes.   The affected area will be subject to  
redness, warmth, swelling and localised tenderness, there is clear demarcated areas and the skin can 
be raised, tight and shiny, (Eagle, 2007, Opoku, 2015).  Typically there is unilateral presentation, with 
bilateral leg cellulitis being very rare,  (NICE, 2015). 
Laboratory investigations can aid diagnosis, CREST (2005), state that although non-specific nearly all 
patients with cellulitis will have a raised White Cell Count (WCC) and elevated Erythrocyte 
Sedimentation Rate (ESR) or C-reactive protein (CRP) and that normal blood inflammatory markers 
make the diagnosis of cellulitis less likely.  However, normal WCC does not exclude cellulitis.  
Lazzarini et al. (2005) found that only 50% of patients admitted with cellulitis had a raised WCC, and 
that ESR and CRP were much more sensitive markers with increases observed in 85% and 97% of 
patients respectively.   The use of a diagnostic checklist can help prevent mis-diagnosis, the checklist 
produced by Opoku (2015) offers an excellent practical tool to aid accurate diagnosis, (Figure 1). 
Classification 
Classification of severity can be useful in terms of admission and treatment decisions. The Eron 
classification (figure 2) is used within CREST Guidelines (2005) and NICE guidelines (2015). 
Figure 2 
Table adapted from CREST (2005). 
Classification Description Treatment 
I 
Patients have no signs of systemic 
toxicity, have no uncontrolled co-
morbidities and can usually be 
managed  with oral antimicrobials on 
an outpatient basis 
Oral antibiotic therapy 
Identification and management of 
underlying risk factors. 
II 
Patients are either systemically ill or 
systemically well but with a co-
morbidity such a peripheral vascular 
disease, chronic venous insufficiency 
or morbid obesity which may 
complicate or delay resolution of their 
infection 
Requires IV antibiotics. 
Admission may not be necessary if 
there are facilities and expertise in 
community 
Commented [LC1]: Need to see if we can re publish 
this – was published in wounds uk originally? 
III 
Patients may have a significant 
systemic upset such as acute 
confusion, tachycardia, tachypnoea, 
hypotension, or may have unstable co-
morbidities that may interfere with a 
response to therapy or have a limb 
threatening infection due to vascular 
compromise 
Admit to hospital for IV antibiotics 
and careful monitoring 
IV Patients have sepsis syndrome or 
severe life threatening infections such 
as necrotizing fasciitis 
Admit to hospital for IV antibiotics 
and treatment of sepsis. 
    
 
Treatment 
Staph aureus is the most common cause of cellulitis, this has been found to be the causative bacteria 
in between 59% and 76% of cases, (Moran et al., 2006, Lee et al., 2015).  Individualised bacterial 
identification from microbiology is often difficult due to the low recovery rate from needle aspirates, 
skin biopsies and blood cultures, (Jeng et al., 2010).  The choice of which antimicrobial agent to use 
will be governed by the suspected bacteria involved and steered by local antibiotic guidelines.  
Commonly flucloxacillin is used as first line treatment (Clarithromycin if allergic to penicillin) as this 
covers both streptococcal and staphylococcal infections.  In patients with known lymphoedema 
Amoxicillin by more effective if there is no evidence of folliculitis, pus formation or crusted 
dermatitis, (British Lymphology Society, 2015, NICE, 2015).  Antibiotic should be used for a period of 
7 days.  Before commencing treatment, if possible, mark the area around the extent of infection 
with an appropriate skin marker, this can be useful to monitor responses from antibiotics, (NICE, 
2015).  All patients should be reviewed after 48 hours of commencing treatment, this can be face to 
face or by telephone, depending on clinical judgement, to assess effectiveness of the management 
plan. 
Compression in Cellulitis 
Patients with venous ulceration are at higher risk of developing cellulitis due to the breakdown of 
the protective barrier of the skin, and these patients are often in compression therapy to treat the 
underlying venous hypertension.  It is commonly thought that it is contraindicated to continue 
compression therapy when patients have an acute infection, and in many patients compression 
therapy is routinely stopped if there is evidence of acute cellulites.  This is not definitive, and in fact 
there is an argument for the need of continued compression.  In each episode of cellulitis the 
lymphatic system is challenged, and cellulitis can result in permanent damage to the lymphatics 
system leading to the development of chronic oedema or lymphoedema, (Cox, 2006).   This results in 
an increased risk of recurrence of cellulitis as  oedema, lymphoedema and cellulitis have been 
proven to be strongly associated, (Soo et al., 2008).   The lymphatic changes results in the patients 
entering a continuous cycle of increased chances of oedema where the oedema predisposes patients 
to cellulitis. Additionally, cellulitis is a cause of persistent oedema and any episode of cellulitis 
predisposes to further episodes, (Cox, 2006).  This all results in patients being at increased risk of 
recurrence and long term conditions.  Compression therapy can help support the lymphatic channels 
during this acute episode so therefore does not need to be routinely stopped, however, many 
patients simply will not be able to cope with the compression due to the increased pain from the 
affected area.  But the decision to stop compression should be one based on individual patient 
assessment as opposed standard practice.    
 
Conclusion 
Lower limb cellulitis is a common condition which has both significant morbidity and resource 
implications.  There are many other conditions that mimic the clinical signs of cellulitis, but these can 
easily be distinguished with careful history taking and holistic patient assessment.  Accurate 
diagnosis is vital to ensure effective patient management whilst protecting the limited resources of 
antibiotics.  Additionally practitioners need to treat underlying or predisposing conditions in parallel, 
wherever possible, to optimise treatment, thus reducing the risk of recurrence and improving overall 
quality of care.  
 
Figure 1 
 Taken from Opoku (2015) 
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